<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The therapeutic efficacy of <z:chebi fb="3" ids="16865">GABA</z:chebi> was compared with pyrithioxine and placebo in 432 patients with cerebrovascular disorders by a multi-center (50 hospitals) double-blind clinical trial </plain></SENT>
<SENT sid="1" pm="."><plain>12 tablets (3 g) of <z:chebi fb="3" ids="16865">GABA</z:chebi> and 3 tablets (600 mg) of pyrithioxine were given daily for 8 weeks </plain></SENT>
<SENT sid="2" pm="."><plain>Subjective complaints, neurological and psychiatric findings, activity of daily living were checked at the 4th and 8th weeks after medication </plain></SENT>
<SENT sid="3" pm="."><plain>The global improvement rates in <z:chebi fb="3" ids="16865">GABA</z:chebi>-treated groups were 59% and 70% each after 4 and 8 weeks of medication, and were significantly superior to the other two groups </plain></SENT>
<SENT sid="4" pm="."><plain>Especially on cerebral <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> <z:chebi fb="3" ids="16865">GABA</z:chebi> was more effective than the other two drugs, with statistical significance </plain></SENT>
<SENT sid="5" pm="."><plain>As for improvement rates of symptoms there were significant differences between <z:chebi fb="3" ids="16865">GABA</z:chebi> and the other two drugs in subjective complaints and in psychiatric findings </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of side effects was 5%, 20% and 8% in <z:chebi fb="3" ids="16865">GABA</z:chebi>, pyrithioxine and placebo, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of abnormal laboratory data was 2% (3 cases), 8% (11 cases) and 4% (6 cases), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Those in <z:chebi fb="3" ids="16865">GABA</z:chebi> group were transient and restored to <z:mpath ids='MPATH_458'>normal</z:mpath> values after the trial </plain></SENT>
<SENT sid="9" pm="."><plain>It is concluded from these results that <z:chebi fb="3" ids="16865">GABA</z:chebi> is safe and effective in the treatment of cerebrovascular disorders </plain></SENT>
</text></document>